Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Adrenal Cortical Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00071058
What this trial is testing

Surgery Plus Chemotherapy (Doxorubicin, Vincristine and Etoposide), Mitotane, and Tariquidar to Treat Adrenocortical Cancer

Who this might be right for
Adrenal Cortex Neoplasms
National Cancer Institute (NCI) 50
Testing effectiveness (Phase 2)Looking for participantsNCT06900595
What this trial is testing

Testing the Addition of an Anti-Cancer Drug, Cabozantinib to the Immunotherapy Drug Cemiplimab (REGN2810), in Adolescents and Adults With Advanced Adrenocortical Cancer

Who this might be right for
Locally Advanced Adrenal Cortical CarcinomaMetastatic Adrenal Cortical CarcinomaRecurrent Adrenal Cortical Carcinoma+3 more
National Cancer Institute (NCI) 48
Large-scale testing (Phase 3)Study completedNCT00304070
What this trial is testing

Cisplatin-Based Chemotherapy and/or Surgery in Treating Young Patients With Adrenocortical Tumor

Who this might be right for
Stage I Adrenal Cortical Carcinoma AJCC v7Stage II Adrenal Cortical Carcinoma AJCC v7Stage III Adrenal Cortical Carcinoma AJCC v7+1 more
Children's Oncology Group 78
Not applicableStudy completedNCT04071561
What this trial is testing

Prevention of Conversion in Posterior Retroperitoneal Adrenalectomy by Measuring Preoperative Anatomical Conditions

Who this might be right for
Adrenal TumorAdrenal MassPheochromocytoma+3 more
University of Basel 14
Testing effectiveness (Phase 2)Study completedNCT01255137
What this trial is testing

Phase II Study of Axitinib (AG-013736) With Evaluation of the VEGF-Pathway in Metastatic, Recurrent or Primary Unresectable Adrenocortical Cancer

Who this might be right for
Adrenal Cortex Neoplasms
National Cancer Institute (NCI) 13
Not applicableUnknownNCT05660889
What this trial is testing

Adrenal Vein Sampling as a Tool to Identify Biomarkers That Aid the Diagnosis of Adrenocortical Carcinoma

Who this might be right for
Adrenocortical Carcinoma
Erasmus Medical Center 25
Not applicableStudy completedNCT05815069
What this trial is testing

[18F]AlF-NOTA-pentixather PET/CT in Patients With Suspected Primary Hyperaldosteronism

Who this might be right for
Primary HyperaldosteronismAldosterone-Producing Adenoma
Sichuan Provincial People's Hospital 20
Testing effectiveness (Phase 2)UnknownNCT04318730
What this trial is testing

Phase II Study for Combination of Camrelizumab and Apatinib in the Second-line Treatment of Recurrent or Metastatic Adrenocortical Carcinoma

Who this might be right for
Adrenocortical Carcinoma
West China Hospital 21
Not applicableUnknownNCT05763524
What this trial is testing

European Multicenter Study on Role of Lymph Node Dissection in Surgical Management of Adrenal Cortical Carcinoma

Who this might be right for
Adrenocortical Carcinoma
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 90
Testing effectiveness (Phase 2)WithdrawnNCT00469469
What this trial is testing

Treatment Study Using Bevacizumab for Patients With Adrenocortical Carcinoma

Who this might be right for
Adrenocortical Carcinoma
Dartmouth-Hitchcock Medical Center
Not applicableLooking for participantsNCT06065852
What this trial is testing

National Registry of Rare Kidney Diseases

Who this might be right for
Adenine Phosphoribosyltransferase DeficiencyAH AmyloidosisAHL Amyloidosis+81 more
UK Kidney Association 35,000
Testing effectiveness (Phase 2)Ended earlyNCT00002921
What this trial is testing

S9427, Suramin in Treating Patients With Stage III or Stage IV Adrenocortical Cancer Incurable by Surgery

Who this might be right for
Adrenocortical Carcinoma
SWOG Cancer Research Network 13
Testing effectiveness (Phase 2)Active Not RecruitingNCT02721732
What this trial is testing

Pembrolizumab in Treating Patients With Rare Tumors That Cannot Be Removed by Surgery or Are Metastatic

Who this might be right for
Advanced Malignant Solid NeoplasmCarcinoma of Unknown PrimaryMetastatic Adrenal Gland Pheochromocytoma+16 more
M.D. Anderson Cancer Center 157
Not applicableUnknownNCT02030587
What this trial is testing

Laparoscopic Adrenalectomy Versus Radiofrequency Ablation

Who this might be right for
HyperaldosteronismConn SyndromeAdrenocortical Adenoma
Chinese University of Hong Kong 36
Early research (Phase 1)Looking for participantsNCT07189403
What this trial is testing

DS9051b in Participants With Advanced or Metastatic Adrenocortical Carcinoma and Metastatic Castration-resistant Prostate Cancer

Who this might be right for
Advanced or Metastatic Adrenocortical CarcinomaMetastatic Castration-resistant Prostate Cancer
Daiichi Sankyo 40
Early research (Phase 1)WithdrawnNCT02831179
What this trial is testing

Veliparib, Capecitabine, and Temozolomide in Patients With Advanced, Metastatic, and Recurrent Neuroendocrine Tumor

Who this might be right for
Functional Pancreatic Neuroendocrine TumorMalignant SomatostatinomaMerkel Cell Carcinoma+26 more
Vanderbilt-Ingram Cancer Center
Early research (Phase 1)Looking for participantsNCT06041516
What this trial is testing

A First-in-Human Phase I Trial With Antibody Drug Conjugate ADCT-701 in Neuroendocrine Tumors, Carcinomas and Malignant Peripheral Nerve Sheath Tumors

Who this might be right for
Neuroendocrine CarcinomasNeuroendocrine TumorsCarcinoma, Neuroendocrine+2 more
National Cancer Institute (NCI) 70
Testing effectiveness (Phase 2)UnknownNCT00786110
What this trial is testing

Sorafenib Plus Paclitaxel in Adreno-Cortical-Cancer Patients

Who this might be right for
Adrenocortical Carcinoma
University of Turin, Italy 30
Not applicableLooking for participantsNCT06141369
What this trial is testing

Treatment of Advanced Endocrine Tumor With Iindividualized mRNA Neoantigen Vaccine (mRNA-0523-L001)

Who this might be right for
Adrenal Cortical CarcinomaMedullary Thyroid CancerThymic Neuroendocrine Carcinoma+1 more
Shanghai Jiao Tong University School of Medicine 21
Not applicableStudy completedNCT01234220
What this trial is testing

Adrenal Vein Sampling International Study (AVIS Study)

Who this might be right for
Hyperaldosteronism
University Hospital Padova 2,604
Next Page